TY - JOUR AU - Babjuk, M. AU - Oosterlinck, W. AU - Sylvester, R. AU - Kaasinen, E. AU - Böhle, A. AU - Palou-Redorta, J. PY - 2011 DA - 2011// TI - EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2011.03.017 DO - 10.1016/j.eururo.2011.03.017 ID - Babjuk2011 ER - TY - JOUR AU - Oddens, J. AU - Brausi, M. AU - Sylvester, R. AU - Bono, A. AU - van de Beek, C. AU - van Andel, G. PY - 2013 DA - 2013// TI - Final results of an eORTC-gU cancers group randomized study of maintenance bacillus calmette-guérin in intermediate- and high-risk ta, t1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance JO - Eur Urol VL - 63 UR - https://doi.org/10.1016/j.eururo.2012.10.039 DO - 10.1016/j.eururo.2012.10.039 ID - Oddens2013 ER - TY - JOUR AU - Shahin, O. AU - Thalmann, G. N. AU - Rentsch, C. AU - Mazzucchelli, L. AU - Studer, U. E. PY - 2003 DA - 2003// TI - A retrospective analysis of 153 patients treated with or without intravesical bacillus calmette-guerin for primary stage t1 grade 3 bladder cancer: recurrence, progression and survival JO - J Urol VL - 169 UR - https://doi.org/10.1016/S0022-5347(05)64044-X DO - 10.1016/S0022-5347(05)64044-X ID - Shahin2003 ER - TY - JOUR AU - Hemdan, T. AU - Johansson, R. AU - Jahnson, S. AU - Hellström, P. AU - Tasdemir, I. AU - Malmström, P. U. PY - 2014 DA - 2014// TI - 5-year outcome of a randomized prospective study comparing bacillus calmette-guérin with epirubicin and interferon-α2b in patients with t1 bladder cancer JO - J Urol VL - 191 UR - https://doi.org/10.1016/j.juro.2013.11.005 DO - 10.1016/j.juro.2013.11.005 ID - Hemdan2014 ER - TY - JOUR AU - Jiang, S. -. J. AU - Ye, L. -. Y. AU - Meng, F. -. H. PY - 2016 DA - 2016// TI - Comparison of intravesical bacillus calmette-guerin and mitomycin c administration for non-muscle invasive bladder cancer: a meta-analysis and systematic review JO - Oncol Lett VL - 11 UR - https://doi.org/10.3892/ol.2016.4325 DO - 10.3892/ol.2016.4325 ID - Jiang2016 ER - TY - JOUR AU - Botteman, M. F. AU - Pashos, C. L. AU - Redaelli, A. AU - Laskin, B. AU - Hauser, R. PY - 2003 DA - 2003// TI - The health economics of bladder cancer: a comprehensive review of the published literature JO - PharmacoEconomics VL - 21 UR - https://doi.org/10.1007/BF03262330 DO - 10.1007/BF03262330 ID - Botteman2003 ER - TY - JOUR AU - Lamm, D. L. AU - Blumenstein, B. A. AU - Crissman, J. D. AU - Montie, J. E. AU - Gottesman, J. E. AU - Lowe, B. A. PY - 2000 DA - 2000// TI - Maintenance bacillus calmette-guerin immunotherapy for recurrent tA, t1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study JO - J Urol VL - 163 UR - https://doi.org/10.1016/S0022-5347(05)67707-5 DO - 10.1016/S0022-5347(05)67707-5 ID - Lamm2000 ER - TY - JOUR AU - Cheng, C. W. AU - Ng, M. T. AU - Chan, S. Y. AU - Sun, W. H. PY - 2004 DA - 2004// TI - Low dose bCG as adjuvant therapy for superficial bladder cancer and literature review JO - ANZ J Surg VL - 74 UR - https://doi.org/10.1111/j.1445-2197.2004.02941.x DO - 10.1111/j.1445-2197.2004.02941.x ID - Cheng2004 ER - TY - JOUR AU - Irie, A. AU - Uchida, T. AU - Yamashita, H. AU - Matsumoto, K. AU - Satoh, T. AU - Koh, H. PY - 2003 DA - 2003// TI - Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus calmette-guérin for superficial bladder cancer recurrence JO - International journal of urology: official journal of the Japanese Urological Association VL - 10 UR - https://doi.org/10.1046/j.0919-8172.2003.00607.x DO - 10.1046/j.0919-8172.2003.00607.x ID - Irie2003 ER - TY - JOUR AU - Martinez Piñeiro, J. A. AU - Martinez-Piñeiro, L. AU - Solsona, E. AU - Rodríguez, R. H. AU - Gómez, J. M. AU - Martín, M. G. PY - 2005 DA - 2005// TI - Has a 3-fold decreased dose of bacillus calmette-guerin the same efficacy against recurrences and progression of t1G3 and tis bladder tumors than the standard dose? Results of a prospective randomized trial JO - J Urol VL - 174 UR - https://doi.org/10.1097/01.ju.0000173919.28835.aa DO - 10.1097/01.ju.0000173919.28835.aa ID - Martinez Piñeiro2005 ER - TY - JOUR AU - Yoneyama, T. AU - Ohyama, C. AU - Imai, A. AU - Ishimura, H. AU - Hagisawa, S. AU - Iwabuchi, I. PY - 2008 DA - 2008// TI - Low-dose instillation therapy with bacille calmette-guérin Tokyo 172 strain after transurethral resection: historical cohort study JO - Urology VL - 71 UR - https://doi.org/10.1016/j.urology.2007.11.080 DO - 10.1016/j.urology.2007.11.080 ID - Yoneyama2008 ER - TY - JOUR AU - Mack, D. AU - Frick, J. PY - 1995 DA - 1995// TI - Low-dose bacille calmette-guérin (bCG) therapy in superficial high-risk bladder cancer: a phase iI study with the bCG strain connaught Canada JO - Br J Urol VL - 75 UR - https://doi.org/10.1111/j.1464-410X.1995.tb07308.x DO - 10.1111/j.1464-410X.1995.tb07308.x ID - Mack1995 ER - TY - JOUR AU - Ojea, A. n. t. o. n. i. o. AU - Nogueira, J. o. s. é. L. u. í. s. AU - Solsona, E. d. u. a. r. d. o. AU - Flores, N. i. c. o. l. á. s. AU - Gómez, J. e. s. ú. s. M. a. r. í. a. F. e. r. n. á. n. d. e. z. AU - Molina, J. e. s. ú. s. R. o. d. r. í. g. u. e. z. AU - Chantada, V. e. n. a. n. c. i. o. AU - Camacho, J. o. s. é. E. m. i. l. i. o. AU - Piñeiro, L. u. í. s. M. a. r. t. í. n. e. z. AU - Rodríguez, R. a. f. a. e. l. H. e. r. n. a. n. d. e. z. AU - Isorna, S. a. n. t. i. a. g. o. AU - Blas, M. i. g. u. e. l. AU - Martínez-Piñeiro, J. o. s. é. A. AU - Madero, R. o. s. a. r. i. o. PY - 2007 DA - 2007// TI - A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C JO - European Urology VL - 52 UR - https://doi.org/10.1016/j.eururo.2007.04.062 DO - 10.1016/j.eururo.2007.04.062 ID - Ojea2007 ER - TY - JOUR AU - Babjuk, M. a. r. k. o. AU - Burger, M. a. x. i. m. i. l. i. a. n. AU - Zigeuner, R. i. c. h. a. r. d. AU - Shariat, S. h. a. h. r. o. k. h. F. AU - van Rhijn, B. a. s. W. G. AU - Compérat, E. v. a. AU - Sylvester, R. i. c. h. a. r. d. J. AU - Kaasinen, E. e. r. o. AU - Böhle, A. n. d. r. e. a. s. AU - Palou Redorta, J. o. a. n. AU - Rouprêt, M. o. r. g. a. n. PY - 2013 DA - 2013// TI - EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 JO - European Urology VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.06.003 DO - 10.1016/j.eururo.2013.06.003 ID - Babjuk2013 ER - TY - JOUR AU - Zhu, S. AU - Tang, Y. AU - Li, K. AU - Shang, Z. AU - Jiang, N. AU - Nian, X. PY - 2013 DA - 2013// TI - Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-332 DO - 10.1186/1471-2407-13-332 ID - Zhu2013 ER - TY - JOUR AU - Astram, A. AU - Khadijah, A. AU - Yuri, P. AU - Zulfan, A. AU - Mochtar, C. A. AU - Danarto, R. PY - 2014 DA - 2014// TI - Effective dose and adverse effects of maintenance bacillus calmette-gue'Rin in intermediate and high risk non-muscle invasive bladder cancer: a meta-analysis of randomized clinical trial JO - Acta medica Indonesiana VL - 46 ID - Astram2014 ER - TY - JOUR AU - Qin, X. AU - Wu, K. AU - Xie, L. AU - Zhao, S. AU - Lu, Y. PY - 2014 DA - 2014// TI - Reduced dose of bacillus calmette-guérin versus full dose of bacillus calmette-guérin for non-muscle-invasive bladder cancer after transurethral resection bladder tumor: a meta-analysis of randomized controlled trials JO - Chin Med J VL - 127 ID - Qin2014 ER - TY - JOUR AU - Zeng, S. AU - Yu, X. AU - Ma, C. AU - Zhang, Z. AU - Song, R. AU - Chen, X. PY - 2015 DA - 2015// TI - Low-dose versus standard dose of bacillus calmette-guerin in the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis JO - Medicine VL - 94 UR - https://doi.org/10.1097/MD.0000000000002176 DO - 10.1097/MD.0000000000002176 ID - Zeng2015 ER - TY - JOUR AU - Al Hussein Al Awamlh, B. AU - Lee, R. AU - Chughtai, B. AU - Donat, S. M. AU - Sandhu, J. S. AU - Herr, H. W. PY - 2015 DA - 2015// TI - A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration JO - Urology VL - 85 UR - https://doi.org/10.1016/j.urology.2014.09.041 DO - 10.1016/j.urology.2014.09.041 ID - Al Hussein Al Awamlh2015 ER - TY - JOUR AU - Bachir, B. G. AU - Dragomir, A. AU - Aprikian, A. G. AU - Tanguay, S. AU - Fairey, A. AU - Kulkarni, G. S. PY - 2014 DA - 2014// TI - Contemporary cost-effectiveness analysis comparing sequential bacillus calmette-guerin and electromotive mitomycin versus bacillus calmette-guerin alone for patients with high-risk non-muscle-invasive bladder cancer JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28731 DO - 10.1002/cncr.28731 ID - Bachir2014 ER - TY - JOUR AU - Kulkarni, G. S. AU - Finelli, A. AU - Fleshner, N. E. AU - Jewett, M. A. S. AU - Lopushinsky, S. R. AU - Alibhai, S. M. H. PY - 2007 DA - 2007// TI - Optimal management of high-risk t1G3 bladder cancer: a decision analysis JO - PLoS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040284 DO - 10.1371/journal.pmed.0040284 ID - Kulkarni2007 ER - TY - JOUR AU - Zhang, Y. AU - Denton, B. T. AU - Nielsen, M. E. PY - 2013 DA - 2013// TI - Comparison of surveillance strategies for low-risk bladder cancer patients JO - Medical decision making : an international journal of the Society for Medical Decision Making VL - 33 UR - https://doi.org/10.1177/0272989X12465353 DO - 10.1177/0272989X12465353 ID - Zhang2013 ER - TY - JOUR AU - Naimark, D. M. J. AU - Bott, M. AU - Krahn, M. PY - 2008 DA - 2008// TI - The half-cycle correction explained: two alternative pedagogical approaches JO - Medical decision making : an international journal of the Society for Medical Decision Making VL - 28 UR - https://doi.org/10.1177/0272989X08315241 DO - 10.1177/0272989X08315241 ID - Naimark2008 ER - TY - JOUR AU - Beck, J. R. AU - Kassirer, J. P. AU - Pauker, S. G. PY - 1982 DA - 1982// TI - A convenient approximation of life expectancy (the "DEALE"). i. Validation of the method JO - Am J Med VL - 73 UR - https://doi.org/10.1016/0002-9343(82)90786-0 DO - 10.1016/0002-9343(82)90786-0 ID - Beck1982 ER - TY - JOUR AU - Pfister, C. AU - Kerkeni, W. AU - Rigaud, J. AU - Le Gal, S. AU - Saint, F. AU - Colombel, M. PY - 2014 DA - 2014// TI - Efficacy and tolerance of one-third full dose bacillus calmette-guérin maintenance therapy every 3 months or 6 months: two-year results of uRO-bCG-4 multicenter study JO - International journal of urology: official journal of the Japanese Urological Association VL - 22 UR - https://doi.org/10.1111/iju.12609 DO - 10.1111/iju.12609 ID - Pfister2014 ER - TY - JOUR AU - Martinez-Piñeiro, L. AU - Portillo, J. A. AU - Fernandez, J. M. AU - Zabala, J. A. AU - Cadierno, I. AU - Moyano, J. L. PY - 2015 DA - 2015// TI - Maintenance therapy with 3-monthly bacillus calmette-guerin for 3 years is not superior to standard induction therapy in high-risk non–muscle-invasive urothelial bladder carcinoma: final results of randomised cUETO study 98013 JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2015.02.040 DO - 10.1016/j.eururo.2015.02.040 ID - Martinez-Piñeiro2015 ER - TY - JOUR AU - Heron, M. AU - Hoyert, D. L. AU - Murphy, S. L. AU - Xu, J. AU - Kochanek, K. D. AU - Tejada-Vera, B. PY - 2009 DA - 2009// TI - Deaths: final data for 2006 JO - National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System VL - 57 ID - Heron2009 ER - TY - JOUR AU - Sonnenberg, F. A. AU - Beck, J. R. PY - 1993 DA - 1993// TI - Markov models in medical decision making: a practical guide JO - Medical decision making: an international journal of the Society for Medical Decision Making VL - 13 UR - https://doi.org/10.1177/0272989X9301300409 DO - 10.1177/0272989X9301300409 ID - Sonnenberg1993 ER - TY - JOUR AU - Brausi, M. AU - Oddens, J. AU - Sylvester, R. AU - Bono, A. AU - van de Beek, C. AU - van Andel, G. PY - 2014 DA - 2014// TI - Side effects of bacillus calmette-guérin (bCG) in the treatment of intermediate- and high-risk ta, t1 papillary carcinoma of the bladder: results of the eORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.07.021 DO - 10.1016/j.eururo.2013.07.021 ID - Brausi2014 ER - TY - JOUR AU - Martínez-Piñeiro, J. A. AU - Flores, N. AU - Isorna, S. AU - Solsona, E. AU - Sebastián, J. L. AU - Pertusa, C. PY - 2002 DA - 2002// TI - Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille calmette-guérin with a reduced dose of 27 mg in superficial bladder cancer JO - BJU Int VL - 89 UR - https://doi.org/10.1046/j.1464-410X.2002.02722.x DO - 10.1046/j.1464-410X.2002.02722.x ID - Martínez-Piñeiro2002 ER - TY - JOUR AU - Aziz, A. AU - May, M. AU - Burger, M. AU - Palisaar, R. J. AU - Trinh, Q. D. AU - Fritsche, H. M. PY - 2014 DA - 2014// TI - Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective european multicenter cohort JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2013.12.018 DO - 10.1016/j.eururo.2013.12.018 ID - Aziz2014 ER - TY - JOUR AU - Amling, C. L. AU - Thrasher, J. B. AU - Frazier, H. A. AU - Dodge, R. K. AU - Robertson, J. E. AU - Paulson, D. F. PY - 1994 DA - 1994// TI - Radical cystectomy for stages ta, tis and t1 transitional cell carcinoma of the bladder JO - J Urol VL - 151 UR - https://doi.org/10.1016/S0022-5347(17)34865-6 DO - 10.1016/S0022-5347(17)34865-6 ID - Amling1994 ER - TY - JOUR AU - Leveridge, M. J. AU - Siemens, D. R. AU - Mackillop, W. J. AU - Peng, Y. AU - Tannock, I. F. AU - Berman, D. M. PY - 2015 DA - 2015// TI - Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study JO - Urology VL - 85 UR - https://doi.org/10.1016/j.urology.2014.12.027 DO - 10.1016/j.urology.2014.12.027 ID - Leveridge2015 ER - TY - JOUR AU - Hounsome, L. S. AU - Verne, J. AU - McGrath, J. S. AU - Gillatt, D. A. PY - 2015 DA - 2015// TI - Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010 JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.12.002 DO - 10.1016/j.eururo.2014.12.002 ID - Hounsome2015 ER - TY - JOUR AU - Spaliviero, M. AU - Dalbagni, G. AU - Bochner, B. H. AU - Poon, B. Y. AU - Huang, H. AU - Al-Ahmadie, H. A. PY - 2014 DA - 2014// TI - Clinical outcome of patients with t1 micropapillary urothelial carcinoma of the bladder JO - J Urol VL - 192 UR - https://doi.org/10.1016/j.juro.2014.02.2565 DO - 10.1016/j.juro.2014.02.2565 ID - Spaliviero2014 ER - TY - STD TI - Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, et al. Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer. Med Oncol (Northwood, London, England) 2015; 32:421. ID - ref36 ER - TY - JOUR AU - von der Maase, H. AU - Hansen, S. W. AU - Roberts, J. T. AU - Dogliotti, L. AU - Oliver, T. AU - Moore, M. J. PY - 2000 DA - 2000// TI - Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.17.3068 DO - 10.1200/JCO.2000.18.17.3068 ID - von der Maase2000 ER - TY - JOUR AU - Kaufman, D. S. AU - Shipley, W. U. AU - Feldman, A. S. PY - 2009 DA - 2009// TI - Bladder cancer JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60491-8 DO - 10.1016/S0140-6736(09)60491-8 ID - Kaufman2009 ER -